Literature DB >> 8857959

Soluble L-selectin in the connective tissue diseases.

A D Blann1, P A Sanders, A Herrick, M I Jayson.   

Abstract

Plasma levels of the leucocyte adhesion molecule L-selectin were measured by ELISA in 41 patients with rheumatoid arthritis, 18 with ankylosing spondylitis, 18 with systemic sclerosis and 27 with vasculitis together with 42 age- and sex-matched controls. Low levels of soluble L-selectin were found in systemic sclerosis (797 +/- 302 ng/ml, P < 0.05) and vasculitis (941 +/- 329 ng/ml, P < 0.05) relative to controls (1244 +/- 269 ng/ml). The exact reasons for low levels of soluble L-selectin are unclear, but may reflect reduced shedding from leucocytes and/or strong binding to its cell membrane ligand(s). An approximate inverse relationship between soluble L-selectin and disease severity may have clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857959     DOI: 10.1046/j.1365-2141.1996.7562378.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Elevated serum L-selectin levels and decreased L-selectin expression on CD8(+) lymphocytes in systemic sclerosis.

Authors:  Y Shimada; M Hasegawa; K Takehara; S Sato
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Serum-soluble selectin levels in patients with Behçet's disease.

Authors:  Aşkin Ateş; Olcay Aydintuğ Tiryaki; Umit Olmez; Hüseyin Tutkak
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 2.980

3.  Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE).

Authors:  J Font; P Pizcueta; M Ramos-Casals; R Cervera; M García-Carrasco; M Navarro; M Ingelmo; P Engel
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

4.  Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations.

Authors:  Heloisa Helena Braga Sawaya; Romy Beatriz Christmann de Souza; Solange Carrasco; Claudia Goldenstein-Schainberg
Journal:  Clin Rheumatol       Date:  2009-02-19       Impact factor: 2.980

5.  L-selectin and skin damage in systemic sclerosis.

Authors:  James V Dunne; Stephan F van Eeden; Kevin J Keen
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

6.  Increased L-Selectin on Monocytes Is Linked to the Autoantibody Profile in Systemic Sclerosis.

Authors:  Neža Brezovec; Katja Perdan-Pirkmajer; Tadeja Kuret; Blaž Burja; Snežna Sodin-Šemrl; Saša Čučnik; Katja Lakota
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

7.  Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.

Authors:  Minoru Hasegawa; Yoshihide Asano; Hirahito Endo; Manabu Fujimoto; Daisuke Goto; Hironobu Ihn; Katsumi Inoue; Osamu Ishikawa; Yasushi Kawaguchi; Masataka Kuwana; Fumihide Ogawa; Hiroki Takahashi; Sumiaki Tanaka; Shinichi Sato; Kazuhiko Takehara
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

8.  Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis.

Authors:  Przemyslaw J Kotyla
Journal:  J Int Med Res       Date:  2018-03-20       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.